AIFD
TR EN    
Home Page » PRESS ROOM » Press Releases
Press Releases
2011 Press Releases
AIFD - IEIS - TISD Joint Press Release dated 22.11.2011
22.12.2011
AIFD - IEIS - TISD Joint Press Release dated 21.11.2011
23.11.2011
AIFD Announcement on the “Decree Amending the Decree on Pricing of Medicinal Products for Human Use
12.11.2011
AIFD Press Release on new Health Application Announcement (SUT) dated 5 November 2011
07.11.2011
Melih Memecan Reelected as AİFD chairman
27.05.2011
Pushed To The Limit, Pharmaceutical Sector Calls Off Some Investments
11.05.2011
293 New Drugs Await Regulatory Approval
19.04.2011
Data On Turkey Is Available From AiFD Center For Data And Analysis
08.02.2011
2010 Press Releases
Cost To World From Cancer Is
02.11.2010
Fight Against Super Bacteria And Viruses Gain Momentum
20.10.2010
Turkish Cancer Patients Are Unable To Access New Drugs On Time
25.08.2010
Şükrü Varol Appointed Deputy Secretary General Of The AİFD
15.07.2010
235 New Drug Candidates Currently In Development To Treat Diabetes
13.07.2010
Turkey’s Industrial Property Rights protection record imperiled
03.06.2010
AİFD Appoints New Chairman
31.05.2010
Serious Problem Detected in Drug Tracking System
20.05.2010
Some 2d-Barcode Readers Are Unable To Read 2d-Barcodes On Drug Boxes!
20.05.2010
AİFD warns of "June 1st"
20.05.2010
Aifd Warns: Problems In Distribution Channels Will Arise From Bringing Deadline Forward To Bar Sale Of Non-2d Barcoded Products
14.05.2010
Access of Turkish Cancer Patients to New Medicines Delayed
09.04.2010
New SUT Draft To Impede Access Of Diabetics To New-Generation Medicines In 45 Provinces
10.03.2010
Uncertainties With The Drug Tracking System Put Patients, Sector In A Bind
18.02.2010
Biotechnology Leader Genzyme Joins AIFD
02.02.2010
2009 Press Releases
New pricing decree to shrink pharma industry by 25%
10.12.2009
Pharma compromise reached
03.12.2009
33.4 Million With HIV Still Alive Thanks to Innovative Drugs and Therapies
30.11.2009
Difficulties Expected, Stemming From New Price Decree
20.11.2009
Armed with Innovative Vaccines, World Fights Swine Flu
12.11.2009
On Patient Rights Day, Patient’s Access To Drugs At Stake
26.10.2009
New Pharma Investments At Stake
12.10.2009
New Pricing Decree To Distress Pharma Industry
01.10.2009
Patient Health May Be At Risk
19.09.2009
Association of Research-Based Pharmaceutical Companies (AİFD)
18.09.2009
Effective Struggle Against Cancer Requires New Drugs and Treatments
16.09.2009
AİFD Welcomes IBSA
08.09.2009
Aifd: "Restricting Tobacco Use Will Make Turkey Healthier"
17.07.2009
AİFD: Close Collaboration And Harsh Penalties Key To Combating Counterfeit Drugs
01.07.2009
According To OECD Innovation Is Key To Emerging From The Current Crisis
24.06.2009
Cancer- Related Death Rates Decrease In Developed Countries
18.06.2009
Turkey’s Competitive Power Results To Be Weak In Innovative Drug Researches
09.06.2009
Muhittin Bilgütay is reelected AIFD Chairperson
03.06.2009
Alp Sevindik, AİFD Secretary General and the Chief Operating Officer
13.05.2009
Eczacıbaşı – Baxter Has Become A Member Of Aifd
03.04.2009
Cancer Is Becoming the Disease of Poor Countries
01.04.2009
Japanese pharmaceutical giant in Turkey - 38th Member of Aifd is Astellas
31.03.2009
The Key to Overcome The Crisis is in R&D Investments
04.03.2009
Turkish People Want Faster Access To New Drugs
19.02.2009
Celgene Is The New Member Of Aifd
16.02.2009
Tuba Sözeri Has Become the External Affairs Manager of AİFD
09.02.2009
2008 Press Releases
AİFD Convened its Sixth Ordinary General Assembly
27.05.2008
AİFD: “If adequate conditions are provided, brain-drain can be reversed”
15.04.2008
New R&D Law Will Enhance Investments
26.02.2008
AİFD's Sponsorship Advertisement for İzmir Expo 2015 is in the Economist Magazine
25.02.2008
24 Innovative Drugs at the Service of Patients
06.02.2008
Full Support Provided By Aifd for EXPO 2015
04.02.2008
Muhittin Bilgütay Elected As New Chairman Of AİFD
07.01.2008
2007 Press Releases
Research-Based Pharmaceutical Companies Support Fight Against Counterfeit Medicines
30.09.2007
FDA’s Former Associate Commissioner for External Relations, Pitts:"SAFE DRUGS SHOULD BE PRESENTED TO PATIENTS MORE EXPEDITIOUSLY"
11.07.2007
This Years’ Final Activity of the Patient School will take place at the School of Medicine of İstanbul University
19.06.2007
MEMBER LOGIN
İşletim sisteminiz Flash Ögeleri Desteklemiyor. Yüklemek için tıklayınız.
INSIDER AIFD
Right strategies will lead Turkey to a bright future
SEARCH IN SITE
DID YOU KNOW THAT…? IMPORTANT TERMS SITE MAP USEFUL LINKS CONFIDENTIALITY-TERMS OF USE CONTACT
Abbott • Actelion • AIFD • Alcon • Alexion İlaç Ticaret Ltd. Şti. • Allergan İlaçları Ticaret A.Ş. • Amgen • Astellas • AstraZeneca • Bausch+Lomb Sağlık Optik Ürünleri Tic. A.Ş. • Bayer Türk Kimya San. Ltd. Şti. • Boehringer Ingelheim • Bristol-Myers Squibb • Celgene • Chiesi • Daiichi-Sankyo • Eczacıbaşı-Baxter • Ferring • Fresenius Kabi • Gilead Sciences İlaç.Tic. Ltd. Şti. • GlaxoSmithKline • IBSA İlaç San. ve Tic. Ltd. Şti. • Intendis • ISection • İ.E.Ulagay • Johnson&Johnson • Lilly • Lundbeck İlaç Tic.Ltd. Şti. • Merck Serono • MSD Türkiye • Nestle • Novartis Sağlık Ürünleri • Novo Nordisk • Nutricia Klinik Beslenme • OTHERS • Pfizer İlaçları Ltd. Şti • Roche Müstahzarları San. A.Ş. • Sanofi-aventis • Servier • Takeda İlaçları Tic Ltd Şti • U.C.B. Pharma •
AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).    
© Association of Research-Based Pharmaceutical Companies Last Update : 02.02.2012
XHTML 1.1 CSS